Variant report

Variant	rs35675346
Chromosome Location	chr16:30936081-30936082
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:10)
CpG islands
(count:0)
Chromatin interactive
region (count:23)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:10 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	MAZ	chr16:30935751-30936129	GM12878	blood:	n/a	chr16:30935869-30935879 chr16:30935764-30935783
2	MXI1	chr16:30932725-30936575	IMR90	lung:	n/a	n/a
3	ZBTB7A	chr16:30934673-30936530	K562	blood:	n/a	n/a
4	MAZ	chr16:30932745-30936180	IMR90	lung:	n/a	chr16:30936153-30936162 chr16:30935869-30935879 chr16:30935316-30935326 chr16:30935764-30935783 chr16:30935631-30935641
5	ZBTB7A	chr16:30934741-30936207	ECC-1	luminal epithelium:	n/a	n/a
6	POLR2A	chr16:30935595-30936132	HepG2	liver:	n/a	n/a
7	POLR2A	chr16:30932906-30936186	H1-hESC	embryonic stem cell:	n/a	n/a
8	ELF1	chr16:30935426-30936124	GM12878	blood:	n/a	n/a
9	EGR1	chr16:30935819-30936104	K562	blood:	n/a	chr16:30935983-30935992 chr16:30935979-30935993 chr16:30935982-30935995 chr16:30935982-30935995 chr16:30935986-30935996
10	ZBTB7A	chr16:30934504-30936302	K562	blood:	n/a	n/a

No data

(count:23 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr16:30775945..30778308-chr16:30932961..30936468,4	MCF-7	breast:
2	chr16:30708299..30711208-chr16:30931702..30936734,5	MCF-7	breast:
3	chr16:30902291..30910124-chr16:30929571..30937617,16	K562	blood:
4	chr16:30903642..30909138-chr16:30932304..30936727,12	MCF-7	breast:
5	chr16:30885239..30889762-chr16:30932057..30936596,5	K562	blood:
6	chr16:30933224..30936181-chr16:31190353..31192929,3	MCF-7	breast:
7	chr16:30795105..30800041-chr16:30931976..30937405,9	MCF-7	breast:
8	chr16:30933863..30936209-chr16:30967329..30971439,5	MCF-7	breast:
9	chr16:30931053..30936697-chr16:30966530..30971104,6	MCF-7	breast:
10	chr16:30902664..30909579-chr16:30931454..30940613,20	MCF-7	breast:
11	chr16:30783772..30791593-chr16:30931071..30936822,9	MCF-7	breast:
12	chr16:30708050..30711529-chr16:30932244..30936391,8	K562	blood:
13	chr16:30884320..30888249-chr16:30933469..30936807,5	MCF-7	breast:
14	chr16:30933979..30936655-chr16:30960385..30962981,2	MCF-7	breast:
15	chr16:30669272..30672997-chr16:30933501..30936286,4	MCF-7	breast:
16	chr16:30934180..30936242-chr16:30957636..30959919,2	MCF-7	breast:
17	chr16:30904584..30910124-chr16:30931578..30937019,11	K562	blood:
18	chr16:30932533..30936330-chr16:30966882..30969248,5	K562	blood:
19	chr16:30707963..30711732-chr16:30932569..30936139,6	K562	blood:
20	chr16:30932022..30936181-chr16:30958194..30961985,7	K562	blood:
21	chr16:30935927..30937493-chr16:31190517..31192070,2	K562	blood:
22	chr16:30931619..30936181-chr16:30955998..30963201,14	K562	blood:
23	chr16:30784974..30791554-chr16:30930641..30936449,8	MCF-7	breast:

No data

Variant related genes	Relation type
FBXL19	TF binding region
FBXL19-AS1	TF binding region
ENSG00000099385	Chromatin interaction
ENSG00000089280	Chromatin interaction
ENSG00000262026	Chromatin interaction
ENSG00000099381	Chromatin interaction
ENSG00000156860	Chromatin interaction
ENSG00000103549	Chromatin interaction
ENSG00000080603	Chromatin interaction
ENSG00000262721	Chromatin interaction
ENSG00000260083	Chromatin interaction
ENSG00000261840	Chromatin interaction
ENSG00000102870	Chromatin interaction
ENSG00000175938	Chromatin interaction
ENSG00000150281	Chromatin interaction
ENSG00000211591	Chromatin interaction
ENSG00000261487	Chromatin interaction
ENSG00000265991	Chromatin interaction

Extended variants
information (count: 118 )
Associated
traits (count: 7 )

rSNPs within LD-proxies of this variant (count:99)

rs_ID	r²[population]
rs1046276	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];1.00[JPT][hapmap];0.86[MEX][hapmap];0.82[ASN][1000 genomes]
rs1060506	0.84[GIH][hapmap];1.00[JPT][hapmap]
rs10782001	1.00[CHB][hapmap];0.89[JPT][hapmap];0.90[ASN][1000 genomes]
rs10782002	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];0.89[JPT][hapmap];0.90[ASN][1000 genomes]
rs10871454	1.00[JPT][hapmap]
rs11076	1.00[CHB][hapmap];0.88[JPT][hapmap];0.84[ASN][1000 genomes]
rs11150599	0.84[CHD][hapmap];0.88[JPT][hapmap]
rs11150600	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];0.89[JPT][hapmap];0.90[ASN][1000 genomes]
rs11150601	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];0.89[JPT][hapmap];0.84[ASN][1000 genomes]
rs11150604	1.00[JPT][hapmap]
rs11640534	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];0.89[JPT][hapmap];0.90[ASN][1000 genomes]
rs11640961	1.00[CHB][hapmap];0.91[CHD][hapmap];0.89[JPT][hapmap]
rs11649653	1.00[CHB][hapmap];0.91[CHD][hapmap];1.00[JPT][hapmap];0.82[ASN][1000 genomes]
rs11862744	1.00[JPT][hapmap]
rs11864839	1.00[JPT][hapmap]
rs11865038	1.00[JPT][hapmap]
rs11865499	0.84[GIH][hapmap];1.00[JPT][hapmap]
rs12445568	0.84[GIH][hapmap]
rs12445650	1.00[JPT][hapmap]
rs12599631	0.90[ASN][1000 genomes]
rs12917722	0.90[ASN][1000 genomes]
rs12924903	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];1.00[JPT][hapmap];0.91[MEX][hapmap];0.87[ASN][1000 genomes]
rs12926295	0.84[CHD][hapmap];0.88[JPT][hapmap]
rs12928852	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];0.89[JPT][hapmap];0.90[ASN][1000 genomes]
rs12930545	1.00[CHB][hapmap];0.83[CHD][hapmap];0.84[GIH][hapmap];0.83[MEX][hapmap];0.90[ASN][1000 genomes]
rs12930657	0.90[ASN][1000 genomes]
rs12931046	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];0.89[JPT][hapmap];0.84[ASN][1000 genomes]
rs13336347	0.90[ASN][1000 genomes]
rs13708	1.00[CHB][hapmap];0.89[JPT][hapmap];0.84[ASN][1000 genomes]
rs14235	1.00[JPT][hapmap]
rs1458201	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];0.89[JPT][hapmap];0.91[MEX][hapmap];1.00[TSI][hapmap];0.91[AMR][1000 genomes];0.99[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs1458202	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];0.89[JPT][hapmap];0.90[ASN][1000 genomes]
rs1870293	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];0.89[JPT][hapmap];0.91[MEX][hapmap];0.84[ASN][1000 genomes]
rs1978487	1.00[JPT][hapmap]
rs2032915	1.00[JPT][hapmap]
rs2054213	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];0.89[JPT][hapmap];0.84[ASN][1000 genomes]
rs2303222	1.00[JPT][hapmap]
rs2303223	1.00[JPT][hapmap]
rs2305880	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];0.89[JPT][hapmap];0.82[ASN][1000 genomes]
rs2305884	1.00[CHB][hapmap];0.91[CHD][hapmap];0.86[GIH][hapmap];0.89[JPT][hapmap];0.84[ASN][1000 genomes]
rs2359612	1.00[JPT][hapmap]
rs28360557	0.84[ASN][1000 genomes]
rs34873012	0.83[ASN][1000 genomes]
rs35468353	1.00[JPT][hapmap]
rs35733741	0.90[ASN][1000 genomes]
rs3751855	1.00[JPT][hapmap]
rs3813020	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];0.90[ASN][1000 genomes]
rs4468641	1.00[JPT][hapmap]
rs4527034	1.00[JPT][hapmap]
rs4889514	0.90[ASN][1000 genomes]
rs4889525	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];0.89[JPT][hapmap];0.84[ASN][1000 genomes]
rs4889534	0.84[CEU][hapmap]
rs4889571	0.90[ASN][1000 genomes]
rs4889599	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];0.89[JPT][hapmap];0.84[ASN][1000 genomes]
rs4889603	0.91[CHD][hapmap];0.89[JPT][hapmap];0.84[ASN][1000 genomes]
rs4889604	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];0.89[JPT][hapmap];0.84[ASN][1000 genomes]
rs4889606	0.89[JPT][hapmap]
rs4889609	1.00[CHB][hapmap];0.82[GIH][hapmap];1.00[JPT][hapmap]
rs4889614	0.84[CEU][hapmap]
rs4889651	0.84[CEU][hapmap];0.91[CHD][hapmap];0.88[JPT][hapmap]
rs4889653	0.84[CEU][hapmap];0.91[CHD][hapmap];0.88[JPT][hapmap]
rs6565217	1.00[JPT][hapmap]
rs6950	1.00[CHB][hapmap];0.89[JPT][hapmap];0.84[ASN][1000 genomes]
rs7184567	1.00[CHB][hapmap]
rs7185007	0.94[AMR][1000 genomes];1.00[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs7196726	1.00[JPT][hapmap]
rs7197717	1.00[JPT][hapmap]
rs7199949	1.00[JPT][hapmap]
rs7200879	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.95[MEX][hapmap];1.00[TSI][hapmap];0.95[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs7203999	0.84[GIH][hapmap];0.89[JPT][hapmap]
rs7204459	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];0.89[JPT][hapmap];0.82[ASN][1000 genomes]
rs7206511	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];0.89[JPT][hapmap];0.90[ASN][1000 genomes]
rs72799341	0.94[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs7294	1.00[JPT][hapmap]
rs729482	1.00[CHB][hapmap];0.81[GIH][hapmap];1.00[JPT][hapmap]
rs732172	1.00[JPT][hapmap]
rs749670	1.00[JPT][hapmap]
rs749671	1.00[JPT][hapmap]
rs749767	1.00[JPT][hapmap]
rs750952	1.00[JPT][hapmap]
rs8046707	1.00[CHB][hapmap];0.91[CHD][hapmap];0.89[JPT][hapmap];0.82[ASN][1000 genomes]
rs8050588	0.84[GIH][hapmap];0.89[JPT][hapmap];0.90[ASN][1000 genomes]
rs8050894	1.00[JPT][hapmap]
rs8052245	0.82[ASN][1000 genomes]
rs8056842	1.00[JPT][hapmap]
rs8060857	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];0.89[JPT][hapmap];0.84[ASN][1000 genomes]
rs8062719	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];0.89[JPT][hapmap];0.86[MEX][hapmap];0.80[ASN][1000 genomes]
rs8063565	0.84[CEU][hapmap];0.88[JPT][hapmap]
rs881929	1.00[JPT][hapmap]
rs889555	0.81[GIH][hapmap];1.00[JPT][hapmap]
rs897986	1.00[CHB][hapmap];0.91[CHD][hapmap];0.84[GIH][hapmap];0.89[JPT][hapmap];0.84[ASN][1000 genomes]
rs9319588	0.84[ASN][1000 genomes]
rs9923231	1.00[JPT][hapmap]
rs9926533	0.89[JPT][hapmap]
rs9933843	0.91[CHD][hapmap];0.88[JPT][hapmap]
rs9934438	1.00[JPT][hapmap]
rs9938050	0.83[ASN][1000 genomes]
rs9938550	0.83[CHD][hapmap];0.84[GIH][hapmap];0.83[MEX][hapmap];0.84[ASN][1000 genomes]
rs9939417	1.00[JPT][hapmap]

Variant overlapped rSNPs/rCNVs (count:19 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1062456	chr16:30442166-31253997	Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	437 gene(s)	inside rSNPs	diseases
2	nsv542898	chr16:30442166-31253997	Enhancers Active TSS Strong transcription Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	437 gene(s)	inside rSNPs	diseases
3	nsv1064134	chr16:30640293-31087327	Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Strong transcription Weak transcription Enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	238 gene(s)	inside rSNPs	diseases
4	nsv905729	chr16:30642867-31247924	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	387 gene(s)	inside rSNPs	diseases
5	esv1825223	chr16:30669091-30971810	Weak transcription Enhancers Strong transcription Bivalent/Poised TSS Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	191 gene(s)	inside rSNPs	diseases
6	nsv431451	chr16:30682399-31340999	Transcr. at gene 5' and 3' Genic enhancers Weak transcription Flanking Active TSS Strong transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	350 gene(s)	inside rSNPs	diseases
7	nsv905733	chr16:30796919-31004812	Weak transcription Enhancers Active TSS Flanking Active TSS Strong transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	112 gene(s)	inside rSNPs	diseases
8	nsv869652	chr16:30799471-30951038	Bivalent Enhancer Strong transcription Weak transcription Active TSS Flanking Active TSS Enhancers Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA	70 gene(s)	inside rSNPs	diseases
9	nsv833189	chr16:30819708-30960795	Active TSS Weak transcription Strong transcription Enhancers Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA	79 gene(s)	inside rSNPs	diseases
10	nsv833190	chr16:30845051-31007863	Enhancers Genic enhancers Strong transcription Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	105 gene(s)	inside rSNPs	diseases
11	nsv833191	chr16:30864242-31048051	Flanking Active TSS Weak transcription Enhancers Strong transcription Active TSS Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	115 gene(s)	inside rSNPs	diseases
12	nsv905734	chr16:30877544-31191482	Active TSS Strong transcription Weak transcription Enhancers ZNF genes & repeats Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	271 gene(s)	inside rSNPs	diseases
13	nsv905735	chr16:30890538-31247924	Strong transcription Genic enhancers Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	264 gene(s)	inside rSNPs	diseases
14	nsv905736	chr16:30900235-30995528	Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent/Poised TSS Genic enhancers Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	83 gene(s)	inside rSNPs	diseases
15	nsv905737	chr16:30900235-31014179	Enhancers Flanking Active TSS Weak transcription Transcr. at gene 5' and 3' Genic enhancers Active TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	95 gene(s)	inside rSNPs	diseases
16	nsv457483	chr16:30903679-31191482	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers Strong transcription Enhancers ZNF genes & repeats Weak transcription Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	253 gene(s)	inside rSNPs	diseases
17	nsv571820	chr16:30903679-31191482	Enhancers Genic enhancers Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	253 gene(s)	inside rSNPs	diseases
18	nsv905738	chr16:30906274-30973926	Strong transcription Weak transcription Active TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	76 gene(s)	inside rSNPs	diseases
19	esv3393315	chr16:30933876-30936424	Active TSS Enhancers Flanking Active TSS Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	29 gene(s)	inside rSNPs	n/a

mRNA abundance (count:7)

SNP	Gene	Cis/trans	Tissue	Source
rs35675346	SLC5A2	cis	cerebellum	SCAN
rs35675346	MYST1	cis	cerebellum	SCAN
rs35675346	PHKG2	cis	parietal	SCAN
rs35675346	GCFC1	trans	cerebellum	SCAN
rs35675346	ITGAX	cis	parietal	SCAN
rs35675346	MYST1	cis	parietal	SCAN
rs35675346	MYST1	Cis_1M	lymphoblastoid	RTeQTL

Chromatin state (count:125 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:30932200-30936600	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
2	chr16:30932800-30936200	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
3	chr16:30932800-30936200	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
4	chr16:30932800-30936400	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
5	chr16:30932800-30936400	Active TSS	Fetal Kidney	kidney
6	chr16:30932800-30936800	Active TSS	HUES48 Cell Line	embryonic stem cell
7	chr16:30932800-30936800	Active TSS	HUES64 Cell Line	embryonic stem cell
8	chr16:30932800-30936800	Active TSS	iPS-20b Cell Line	embryonic stem cell
9	chr16:30932800-30936800	Active TSS	HSMM	muscle
10	chr16:30932800-30937000	Active TSS	iPS-18 Cell Line	embryonic stem cell
11	chr16:30933000-30936200	Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
12	chr16:30933000-30936200	Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
13	chr16:30933000-30936200	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
14	chr16:30933000-30936200	Active TSS	Pancreatic Islets	Pancreatic Islet
15	chr16:30933000-30936200	Active TSS	HSMMtube	muscle
16	chr16:30933000-30936400	Active TSS	Esophagus	oesophagus
17	chr16:30933000-30936600	Active TSS	iPS-15b Cell Line	embryonic stem cell
18	chr16:30933000-30936600	Active TSS	Brain Inferior Temporal Lobe	brain
19	chr16:30933000-30936800	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
20	chr16:30933000-30936800	Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
21	chr16:30933000-30936800	Active TSS	HUES6 Cell Line	embryonic stem cell
22	chr16:30933200-30936200	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
23	chr16:30933200-30936400	Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr16:30933200-30936400	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
25	chr16:30933200-30936600	Active TSS	H1 Cell Line	embryonic stem cell
26	chr16:30933200-30936800	Active TSS	H9 Cell Line	embryonic stem cell
27	chr16:30933400-30936200	Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
28	chr16:30933400-30936200	Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
29	chr16:30933400-30936600	Active TSS	NHLF	lung
30	chr16:30933600-30936200	Active TSS	GM12878-XiMat	blood
31	chr16:30933800-30936600	Active TSS	Rectal Mucosa Donor 31	rectum
32	chr16:30935200-30936400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
33	chr16:30935200-30941600	Weak transcription	Brain Substantia Nigra	brain
34	chr16:30935400-30936200	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
35	chr16:30935400-30936200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
36	chr16:30935400-30936200	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
37	chr16:30935400-30936400	Active TSS	ES-I3 Cell Line	embryonic stem cell
38	chr16:30935400-30936400	Enhancers	Primary B cells from cord blood	blood
39	chr16:30935400-30936400	Flanking Active TSS	Primary hematopoietic stem cells	blood
40	chr16:30935400-30936800	Active TSS	NHDF-Ad	bronchial
41	chr16:30935600-30936200	Flanking Active TSS	Right Ventricle	heart
42	chr16:30935600-30936400	Enhancers	Primary B cells from peripheral blood	blood
43	chr16:30935600-30936400	Enhancers	Primary T cells fromperipheralblood	blood
44	chr16:30935600-30936400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
45	chr16:30935600-30936400	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
46	chr16:30935600-30936600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
47	chr16:30935600-30936600	Flanking Active TSS	Colonic Mucosa	Colon
48	chr16:30935600-30936600	Flanking Active TSS	Stomach Smooth Muscle	stomach
49	chr16:30935600-30943400	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
50	chr16:30935800-30936200	Active TSS	Primary T cells from cord blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links